nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adaptation of a commercial fluorescent in situ hybridization test to the diagnosis of malignant cells in effusions
|
Flores-Staino, Carmen |
|
2010 |
68 |
1 |
p. 39-43 5 p. |
artikel |
2 |
A fast and convenient new technique to detect the therapeutic target, K-ras mutant, from peripheral blood in non-small cell lung cancer patients
|
Tsao, Der-An |
|
2010 |
68 |
1 |
p. 51-57 7 p. |
artikel |
3 |
Age-related impairment of quality of life after lung resection for non-small cell lung cancer
|
Schulte, Tobias |
|
2010 |
68 |
1 |
p. 115-120 6 p. |
artikel |
4 |
Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?
|
Bastide, Kristell |
|
2010 |
68 |
1 |
p. 1-9 9 p. |
artikel |
5 |
Clinical significance of cancer/testis antigens expression in patients with non-small cell lung cancer
|
Shigematsu, Yoshiki |
|
2010 |
68 |
1 |
p. 105-110 6 p. |
artikel |
6 |
Comparison of squamous cell carcinoma and adenocarcinoma of the lung by metabolomic analysis of tissue–serum pairs
|
Jordan, K.W. |
|
2010 |
68 |
1 |
p. 44-50 7 p. |
artikel |
7 |
Contents
|
|
|
2010 |
68 |
1 |
p. vii-viii nvt p. |
artikel |
8 |
Down-regulation of HSP27 sensitizes TRAIL-resistant tumor cell to TRAIL-induced apoptosis
|
Zhuang, Hongqin |
|
2010 |
68 |
1 |
p. 27-38 12 p. |
artikel |
9 |
Editorial Board
|
|
|
2010 |
68 |
1 |
p. v- 1 p. |
artikel |
10 |
Feasibility study of adjuvant chemotherapy with gemcitabine and split-dose cisplatin for completely resected non-small-cell lung cancer
|
Funai, Kazuhito |
|
2010 |
68 |
1 |
p. 78-83 6 p. |
artikel |
11 |
Gemcitabine combined with either pemetrexed or paclitaxel in the treatment of advanced non-small cell lung cancer
|
Comella, Pasquale |
|
2010 |
68 |
1 |
p. 94-98 5 p. |
artikel |
12 |
Impact of malignant mesothelioma in Taiwan: A 27-year review of population-based cancer registry data
|
Lee, Lukas Jyuhn-Hsiarn |
|
2010 |
68 |
1 |
p. 16-19 4 p. |
artikel |
13 |
Is risk of pleural mesothelioma an environmental risk outside Turkey? A study on immigrants to Sweden
|
Mousavi, Seyed Mohsen |
|
2010 |
68 |
1 |
p. 125-126 2 p. |
artikel |
14 |
LAT1 expression in non-small-cell lung carcinomas: Analyses by semiquantitative reverse transcription-PCR (237 cases) and immunohistochemistry (295 cases)
|
Takeuchi, Katsuyuki |
|
2010 |
68 |
1 |
p. 58-65 8 p. |
artikel |
15 |
Limitations of dual time point PET in the assessment of lung nodules with low FDG avidity
|
Cloran, Francis J. |
|
2010 |
68 |
1 |
p. 66-71 6 p. |
artikel |
16 |
Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case–control study
|
Park, Sue K. |
|
2010 |
68 |
1 |
p. 20-26 7 p. |
artikel |
17 |
Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP)
|
Stahel, Rolf |
|
2010 |
68 |
1 |
p. 121-124 4 p. |
artikel |
18 |
Pain in patients with lung cancer: Pathophysiology and treatment
|
Mercadante, Sebastiano |
|
2010 |
68 |
1 |
p. 10-15 6 p. |
artikel |
19 |
Phase II study of the proteasome inhibitor bortezomib (PS-341, Velcade®) in chemotherapy-naïve patients with advanced stage non-small cell lung cancer (NSCLC)
|
Li, Tianhong |
|
2010 |
68 |
1 |
p. 89-93 5 p. |
artikel |
20 |
Phase I trial of carboplatin/paclitaxel/bortezomib and concurrent radiotherapy followed by surgical resection in Stage III non-small cell lung cancer
|
Edelman, Martin J. |
|
2010 |
68 |
1 |
p. 84-88 5 p. |
artikel |
21 |
Pooled analysis of the reports of erlotinib after failure of gefitinib for non-small cell lung cancer
|
Kaira, Kyoichi |
|
2010 |
68 |
1 |
p. 99-104 6 p. |
artikel |
22 |
Stereotactic body radiation therapy for early stage non-small cell lung cancer: Results of a prospective trial
|
Ricardi, Umberto |
|
2010 |
68 |
1 |
p. 72-77 6 p. |
artikel |
23 |
The occurrence of hyponatremia in SCLC and the influence on prognosis
|
Hansen, Olfred |
|
2010 |
68 |
1 |
p. 111-114 4 p. |
artikel |